Management strategies of autoimmune bullous diseases during the outbreak of 2019 Novel Coronavirus disease (COVID-19)
Since late December 2019, an outbreak of the novel coronavirus disease, which is mainly characterized by pulmonary lesions, has spread quickly worldwide. With the spread of the novel coronavirus, the outpatient lines of hospitals have mostly shut down, which means that routine clinical diagnosis and...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-01-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/09546634.2020.1771261 |
| _version_ | 1797683629064716288 |
|---|---|
| author | Pan Chen Guiying Zhang Yi Zhan |
| author_facet | Pan Chen Guiying Zhang Yi Zhan |
| author_sort | Pan Chen |
| collection | DOAJ |
| description | Since late December 2019, an outbreak of the novel coronavirus disease, which is mainly characterized by pulmonary lesions, has spread quickly worldwide. With the spread of the novel coronavirus, the outpatient lines of hospitals have mostly shut down, which means that routine clinical diagnosis and treatment for autoimmune bullous diseases patients have been disturbed. Due to the serious condition of autoimmune bullous diseases patients, they are prone to immune suppression and circulatory failure, and are more susceptible to infection than healthy individuals. These patients should thus be a priority group for novel coronavirus disease prevention. In this context, the protection and control measures for autoimmune bullous diseases patients against the novel coronavirus are of serious concern. Clinicians should strengthen their communication with patients, pay attention to changes in patients’ conditions, and carefully adjust the treatment strategy, while protecting against the novel coronavirus infection, to ensure the continuity, safety, and effectiveness of autoimmune bullous diseases treatment. |
| first_indexed | 2024-03-12T00:17:14Z |
| format | Article |
| id | doaj.art-ac2c993abeed4d12b7bbd1f681a09b25 |
| institution | Directory Open Access Journal |
| issn | 0954-6634 1471-1753 |
| language | English |
| last_indexed | 2024-03-12T00:17:14Z |
| publishDate | 2022-01-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of Dermatological Treatment |
| spelling | doaj.art-ac2c993abeed4d12b7bbd1f681a09b252023-09-15T14:23:06ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532022-01-0133156957010.1080/09546634.2020.17712611771261Management strategies of autoimmune bullous diseases during the outbreak of 2019 Novel Coronavirus disease (COVID-19)Pan Chen0Guiying Zhang1Yi Zhan2Department of Dermatology, Second Xiangya Hospital, Central South UniversityDepartment of Dermatology, Second Xiangya Hospital, Central South UniversityDepartment of Dermatology, Second Xiangya Hospital, Central South UniversitySince late December 2019, an outbreak of the novel coronavirus disease, which is mainly characterized by pulmonary lesions, has spread quickly worldwide. With the spread of the novel coronavirus, the outpatient lines of hospitals have mostly shut down, which means that routine clinical diagnosis and treatment for autoimmune bullous diseases patients have been disturbed. Due to the serious condition of autoimmune bullous diseases patients, they are prone to immune suppression and circulatory failure, and are more susceptible to infection than healthy individuals. These patients should thus be a priority group for novel coronavirus disease prevention. In this context, the protection and control measures for autoimmune bullous diseases patients against the novel coronavirus are of serious concern. Clinicians should strengthen their communication with patients, pay attention to changes in patients’ conditions, and carefully adjust the treatment strategy, while protecting against the novel coronavirus infection, to ensure the continuity, safety, and effectiveness of autoimmune bullous diseases treatment.http://dx.doi.org/10.1080/09546634.2020.1771261covid-19autoimmune bullous diseasespatient managementpersonal protection |
| spellingShingle | Pan Chen Guiying Zhang Yi Zhan Management strategies of autoimmune bullous diseases during the outbreak of 2019 Novel Coronavirus disease (COVID-19) Journal of Dermatological Treatment covid-19 autoimmune bullous diseases patient management personal protection |
| title | Management strategies of autoimmune bullous diseases during the outbreak of 2019 Novel Coronavirus disease (COVID-19) |
| title_full | Management strategies of autoimmune bullous diseases during the outbreak of 2019 Novel Coronavirus disease (COVID-19) |
| title_fullStr | Management strategies of autoimmune bullous diseases during the outbreak of 2019 Novel Coronavirus disease (COVID-19) |
| title_full_unstemmed | Management strategies of autoimmune bullous diseases during the outbreak of 2019 Novel Coronavirus disease (COVID-19) |
| title_short | Management strategies of autoimmune bullous diseases during the outbreak of 2019 Novel Coronavirus disease (COVID-19) |
| title_sort | management strategies of autoimmune bullous diseases during the outbreak of 2019 novel coronavirus disease covid 19 |
| topic | covid-19 autoimmune bullous diseases patient management personal protection |
| url | http://dx.doi.org/10.1080/09546634.2020.1771261 |
| work_keys_str_mv | AT panchen managementstrategiesofautoimmunebullousdiseasesduringtheoutbreakof2019novelcoronavirusdiseasecovid19 AT guiyingzhang managementstrategiesofautoimmunebullousdiseasesduringtheoutbreakof2019novelcoronavirusdiseasecovid19 AT yizhan managementstrategiesofautoimmunebullousdiseasesduringtheoutbreakof2019novelcoronavirusdiseasecovid19 |